![Vassiliki Economides](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vassiliki Economides
Financieel Directeur/CFO bij GRITSTONE BIO, INC.
Vermogen: 203 126 $ op 31-05-2024
Actieve functies van Vassiliki Economides
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GRITSTONE BIO, INC. | Financieel Directeur/CFO | 23-06-2021 | - |
Altum Pharmaceuticals, Inc.
![]() Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - | - |
Loopbaan van Vassiliki Economides
Eerdere bekende functies van Vassiliki Economides
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Investor Relations Contact | 11-07-2016 | 01-03-2019 |
Public Communications Contact | 11-07-2016 | 01-03-2019 | |
Corporate Officer/Principal | 11-07-2016 | 01-03-2019 | |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01-03-2015 | 01-06-2016 |
KEZAR LIFE SCIENCES, INC. | Investor Relations Contact | 04-03-2019 | - |
Public Communications Contact | 04-03-2019 | - | |
PROSENSA HOLDING NV | Investor Relations Contact | - | - |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | - |
Opleiding van Vassiliki Economides
McGill University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 6 |
Canada | 4 |
Nederland | 2 |
Operationeel
Investor Relations Contact | 4 |
Corporate Officer/Principal | 3 |
Public Communications Contact | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Prosensa Holding NV
![]() Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Altum Pharmaceuticals, Inc.
![]() Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Health Technology |